Jianfeng Group Lin2015 -001 (Announcement of Jianfeng Group on Progress of Naisikang)
Release time:
2020-08-05
Securities Abbreviations: Jianfeng Group Securities Code: 600668 Number: Pro 2015-001
Bond Abbreviations: 13 Spike 01 Bond Code: 122227
Bond Abbreviations: 13 Spike 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Progress Announcement on Jianfeng Pharmaceutical's Acquisition of Naisikang's Equity
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assume individual and joint responsibility for the truthfulness, accuracy and completeness of its contents.
2014 7 29 , the company once announced that Zhejiang Jianfeng pharmaceutical co., ltd., the controlling subsidiary of the company, signed the "framework agreement on equity transfer of Zhejiang nesikang pharmaceutical co., ltd." (hereinafter referred to as the "framework agreement") with Creative Medicine and Xi' an zizhitong investment co., ltd, it is proposed to transfer its 70% and 25% stake in Zhejiang Niskang Pharmaceutical Co., Ltd. For the above matters, please refer to the "Prompt Announcement of Zhejiang Jianfeng Group Co., Ltd. on Signing of Equity Transfer Framework Agreement by Subsidiaries" issued by the Company on , , , , , , , ,
.After the framework agreement was signed, according to the agreement, we hired audit, evaluation and other intermediary agencies with securities qualification to conduct a comprehensive audit, evaluation and due diligence on Zhejiang Nestkang Pharmaceutical Co., Ltd. , and conducted many consultations and negotiations with the equity transferor, however, due to the failure to solve the environmental protection problems of
Zhejiang Naisikang Pharmaceutical Co., Ltd., a consensus could not be reached.In view of the fact that the exclusive period stipulated in the Framework Agreement has expired, after friendly negotiation, all parties jointly decided to terminate the equity transfer of Nessikang Company. On April 13, 2015, parties
signed the Memorandum on Termination of the Framework Agreement on Equity Transfer of Zhejiang Nessikang Pharmaceutical Co., Ltd. The main contents of the memorandum are as follows:1. The parties agree to terminate the Framework Agreement on Equity Transfer of Zhejiang Nestkang Pharmaceutical Co., Ltd. signed on July 28, 2014.
2. Each party shall bear the expenses (audit and evaluation expenses) paid for the above-mentioned equity transfer, and shall not claim compensation or compensation from the other party.
3. Creative Medicine and Xi 'an Zizhitong Investment Co., Ltd. may seek a third party to contact, negotiate and negotiate the above-mentioned equity transfer of Zhejiang Naisikang Pharmaceutical Co., Ltd.
The termination of the equity transfer of Zhejiang Naisikang Pharmaceutical Co., Ltd.
will not have a material adverse impact on the production and operation of the Company.is hereby announced
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08